These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9447945)

  • 1. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
    Gearon CL; Hussain MJ; Vergani D; Peakman M
    Diabetologia; 1997 Dec; 40(12):1388-95. PubMed ID: 9447945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tenidap, a novel anti-inflammatory compound on islet lymphocytic infiltration and diabetes incidence in the non obese diabetic (NOD) mouse.
    Beales PE; Williams A; Krug J; Signore A; Chianelli M; Andreani D; Pozzilli P
    Diabete Metab; 1992; 18(1):48-53. PubMed ID: 1563537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with IA-2 autoantigen can prevent late prediabetic nonobese diabetic mice from developing diabetes mellitus.
    Guan Y; Zhang M; Li Y; Cao W; Ji M; Liu Y
    Diabetes Res Clin Pract; 2012 Jan; 95(1):93-7. PubMed ID: 22004942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
    Luo JH; Zhou ZG; Jiang TJ; Pei JH; Li X; He L; Sun SG
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1791-5. PubMed ID: 15631776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
    Miyazaki A; Hanafusa T; Yamada K; Miyagawa J; Fujino-Kurihara H; Nakajima H; Nonaka K; Tarui S
    Clin Exp Immunol; 1985 Jun; 60(3):622-30. PubMed ID: 3160515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F; Di Marco R; Barcellini W; Magro G; Schorlemmer HU; Kurrle R; Lunetta M; Grasso S; Zaccone P; Meroni P
    Eur J Immunol; 1994 Aug; 24(8):1843-7. PubMed ID: 8056041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats.
    Bellmann K; Kolb H; Rastegar S; Jee P; Scott FW
    Diabetologia; 1998 Jul; 41(7):844-7. PubMed ID: 9686928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.